{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:12:26Z","timestamp":1773663146210,"version":"3.50.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Recent clinical trials using autologous bone marrow or peripheral blood cells to treat myocardial infarction (MI) show controversial results, although the treatment has a good safety profile. These discrepancies are likely caused by factors such as aging, systemic inflammation, and cell processing procedures, all of which might impair the regenerative capability of the cells used. Here, we tested whether injection of human cord blood mononuclear cells (CB-MNCs) combined with hyaluronan (HA) hydrogel improves cell therapy efficacy in a pig MI model. A total of 34 minipigs were divided into 5 groups: sham operation (Sham), surgically induced-MI plus injection with normal saline (MI+NS), HA only (MI+HA), CB-MNC only (MI+CB-MNC), or CB-MNC combined with HA (MI+CB-MNC\/HA). Two months after the surgery, injection of MI+CB-MNC\/HA showed the highest left ventricle ejection fraction (51.32% \u00b1 0.81%) compared with MI+NS (42.87% \u00b1 0.97%, p &amp;lt; .001), MI+HA (44.2% \u00b1 0.63%, p &amp;lt; .001), and MI+CB-MNC (46.17% \u00b1 0.39%, p &amp;lt; .001) groups. The hemodynamics data showed that MI+CB-MNC\/HA improved the systolic function (+dp\/dt) and diastolic function (\u2212dp\/dt) as opposed to the other experimental groups, of which the CB-MNC alone group only modestly improved the systolic function (+dp\/dt). In addition, CB-MNC alone or combined with HA injection significantly decreased the scar area and promoted angiogenesis in the infarcted region. Together, these results indicate that combined CB-MNC and HA treatment improves heart performance and may be a promising treatment for ischemic heart diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>This study using healthy human cord blood mononuclear cells (CB-MNCs) to treat myocardial infarction provides preclinical evidence that combined injection of hyaluronan and human CB-MNCs after myocardial infarction significantly increases cell retention in the peri-infarct area, improves cardiac performance, and prevents cardiac remodeling. Moreover, using healthy cells to replace dysfunctional autologous cells may constitute a better strategy to achieve heart repair and regeneration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2015-0092","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T03:19:04Z","timestamp":1447730344000},"page":"56-66","source":"Crossref","is-referenced-by-count":25,"title":["Injection of Human Cord Blood Cells With Hyaluronan Improves Postinfarction Cardiac Repair in Pigs"],"prefix":"10.1093","volume":"5","author":[{"given":"Ming-Yao","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Ting","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Department of Life Science, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hsi","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiaw-Min","family":"Hwang","sequence":"additional","affiliation":[{"name":"Bioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.H.","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China"},{"name":"Division of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"2021122704430530500_R1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ Res"},{"key":"2021122704430530500_R2","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.112.001035","article-title":"Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: Effects on global left ventricular function","volume":"127","author":"S\u00fcrder","year":"2013","journal-title":"Circulation"},{"key":"2021122704430530500_R3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"2021122704430530500_R4","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: The TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"2021122704430530500_R5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2003.07.025","article-title":"Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting","volume":"42","author":"Scheubel","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2021122704430530500_R6","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","article-title":"Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures","volume":"106","author":"Tepper","year":"2002","journal-title":"Circulation"},{"key":"2021122704430530500_R7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"2021122704430530500_R8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"2021122704430530500_R9","doi-asserted-by":"crossref","first-page":"100ra90","DOI":"10.1126\/scitranslmed.3002814","article-title":"Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response","volume":"3","author":"Wang","year":"2011","journal-title":"Sci Transl Med"},{"key":"2021122704430530500_R10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2141.2009.07828.x","article-title":"Alternative haematopoietic stem cell sources for transplantation: Place of umbilical cord blood","volume":"147","author":"Smith","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122704430530500_R11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2010.05659.x","article-title":"Umbilical cord blood stem cells: What to expect","volume":"1205","author":"Zhong","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2021122704430530500_R12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.5966\/sctm.2014-0151","article-title":"Concise review: Umbilical cord blood transplantation: Past, present, and future","volume":"3","author":"Munoz","year":"2014","journal-title":"Stem Cells Translational Medicine"},{"issue":"suppl 1","key":"2021122704430530500_R13","first-page":"105","article-title":"Human cord blood: A source of transplantable stem cells?","volume":"9","author":"Hows","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"2021122704430530500_R14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-010-0619-4","article-title":"Stem and progenitor cells in human umbilical cord blood","volume":"92","author":"Lee","year":"2010","journal-title":"Int J Hematol"},{"key":"2021122704430530500_R15","doi-asserted-by":"crossref","first-page":"975.e9","DOI":"10.1016\/j.ahj.2006.08.004","article-title":"Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function","volume":"152","author":"Meluz\u00edn","year":"2006","journal-title":"Am Heart J"},{"key":"2021122704430530500_R16","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.ijcard.2013.03.131","article-title":"Enhanced therapeutic effects on acute myocardial infarction with multiple intravenous transplantation of human cord blood mononuclear cells","volume":"168","author":"Yuan","year":"2013","journal-title":"Int J Cardiol"},{"key":"2021122704430530500_R17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"2021122704430530500_R18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/jmcc.2001.1491","article-title":"Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium","volume":"34","author":"M\u00fcller-Ehmsen","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704430530500_R19","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","article-title":"Monitoring of bone marrow cell homing into the infarcted human myocardium","volume":"111","author":"Hofmann","year":"2005","journal-title":"Circulation"},{"key":"2021122704430530500_R20","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/adma.200802106","article-title":"Hydrogels in regenerative medicine","volume":"21","author":"Slaughter","year":"2009","journal-title":"Adv Mater"},{"key":"2021122704430530500_R21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nmat2441","article-title":"Complexity in biomaterials for tissue engineering","volume":"8","author":"Place","year":"2009","journal-title":"Nat Mater"},{"key":"2021122704430530500_R22","doi-asserted-by":"crossref","first-page":"160sr4","DOI":"10.1126\/scitranslmed.3002717","article-title":"Designing regenerative biomaterial therapies for the clinic","volume":"4","author":"Pashuck","year":"2012","journal-title":"Sci Transl Med"},{"key":"2021122704430530500_R23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt1055","article-title":"Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering","volume":"23","author":"Lutolf","year":"2005","journal-title":"Nat Biotechnol"},{"key":"2021122704430530500_R24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.CIR.0000153847.47301.80","article-title":"Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells","volume":"111","author":"Davis","year":"2005","journal-title":"Circulation"},{"key":"2021122704430530500_R25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.addr.2007.08.008","article-title":"Hyaluronan-dependent pericellular matrix","volume":"59","author":"Evanko","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"2021122704430530500_R26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biomaterials.2010.08.085","article-title":"The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan","volume":"32","author":"Tang","year":"2011","journal-title":"Biomaterials"},{"key":"2021122704430530500_R27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/mt.2012.268","article-title":"Hyaluronan enhances bone marrow cell therapy for myocardial repair after infarction","volume":"21","author":"Chen","year":"2013","journal-title":"Mol Ther"},{"key":"2021122704430530500_R28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122704430530500_R29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"2021122704430530500_R30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122704430530500_R31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCRESAHA.114.303720","article-title":"Bone marrow mononuclear cell therapy for acute myocardial infarction: A perspective from the cardiovascular cell therapy research network","volume":"114","author":"Simari","year":"2014","journal-title":"Circ Res"},{"key":"2021122704430530500_R32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","article-title":"Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes","volume":"53","author":"Loomans","year":"2004","journal-title":"Diabetes"},{"key":"2021122704430530500_R33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.coi.2011.05.007","article-title":"Inflammation and mesenchymal stem cell aging","volume":"23","author":"Lepperdinger","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"suppl 4","key":"2021122704430530500_R34","first-page":"S4-005","article-title":"Human umbilical cord blood for transplantation therapy in myocardial infarction","volume":"pii","author":"Acosta","year":"2013","journal-title":"J Stem Cell Res Ther"},{"key":"2021122704430530500_R35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/pr.2011.59","article-title":"Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy","volume":"71","author":"Pimentel-Coelho","year":"2012","journal-title":"Pediatr Res"},{"key":"2021122704430530500_R36","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.275.14.10105","article-title":"The nonreceptor protein-tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells","volume":"275","author":"Kanda","year":"2000","journal-title":"J Biol Chem"},{"key":"2021122704430530500_R37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neulet.2005.01.070","article-title":"Human umbilical cord blood cells express neurotrophic factors","volume":"380","author":"Fan","year":"2005","journal-title":"Neurosci Lett"},{"key":"2021122704430530500_R38","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood-2005-09-012807","article-title":"Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment","volume":"108","author":"Kobayashi","year":"2006","journal-title":"Blood"},{"key":"2021122704430530500_R39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cvr\/cvp062","article-title":"Cardioprotective growth factors","volume":"83","author":"Hausenloy","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2021122704430530500_R40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","article-title":"Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke","volume":"15","author":"Liesz","year":"2009","journal-title":"Nat Med"},{"key":"2021122704430530500_R41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurheartj\/ehn566","article-title":"Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells","volume":"30","author":"Stellos","year":"2009","journal-title":"Eur Heart J"},{"issue":"suppl","key":"2021122704430530500_R42","first-page":"S132","article-title":"Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs","volume":"122","author":"Lin","year":"2010","journal-title":"Circulation"},{"key":"2021122704430530500_R43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biomaterials.2004.02.058","article-title":"Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium","volume":"26","author":"Ryu","year":"2005","journal-title":"Biomaterials"},{"key":"2021122704430530500_R44","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1016\/j.biomaterials.2011.06.049","article-title":"A combined cell therapy and in-situ tissue-engineering approach for myocardial repair","volume":"32","author":"Habib","year":"2011","journal-title":"Biomaterials"},{"key":"2021122704430530500_R45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2004.04.040","article-title":"Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium","volume":"44","author":"Christman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2021122704430530500_R46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/bm401583b","article-title":"Clearance kinetics of biomaterials affects stem cell retention and therapeutic efficacy","volume":"15","author":"Lai","year":"2014","journal-title":"Biomacromolecules"},{"key":"2021122704430530500_R47","doi-asserted-by":"crossref","first-page":"H1078","DOI":"10.1152\/ajpheart.00801.2013","article-title":"Injection of autologous bone marrow cells in hyaluronan hydrogel improves cardiac performance after infarction in pigs","volume":"306","author":"Chen","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021122704430530500_R48","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00248.2011","article-title":"Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism","volume":"302","author":"Riehl","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2021122704430530500_R49","doi-asserted-by":"crossref","first-page":"34936","DOI":"10.1074\/jbc.C600138200","article-title":"Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells","volume":"281","author":"Misra","year":"2006","journal-title":"J Biol Chem"},{"key":"2021122704430530500_R50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2012.11.006","article-title":"Hyaluronic acid-dependent protection in H9C2 cardiomyocytes: A cell model of heart ischemia-reperfusion injury and treatment","volume":"303","author":"Law","year":"2013","journal-title":"Toxicology"},{"key":"2021122704430530500_R51","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.2583074.x","article-title":"Endothelial cell precursors are normal components of human umbilical cord blood","volume":"98","author":"Nieda","year":"1997","journal-title":"Br J Haematol"},{"key":"2021122704430530500_R52","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","article-title":"Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization","volume":"97","author":"Kalka","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704430530500_R53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/xen.12026","article-title":"Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction","volume":"20","author":"Gahremanpour","year":"2013","journal-title":"Xenotransplantation"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0092","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0092","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/56\/41866854\/stcltm_5_1_56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/56\/41866854\/stcltm_5_1_56.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:49:51Z","timestamp":1642560591000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/5\/1\/56-66\/6397873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,16]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0092","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2015,11,16]]}}}